Ozempic

With semaglutide patents set to expire in 2026, Indian drugmakers are preparing to enter the market with generics. This…

GlobalData’s latest report showcases an analysis of the GLP-1R agonists pipeline in multiple indications, highlighting the areas…

The approval was based on data from a late-stage study, which showed that Ozempic helped cut the risk of death from chronic kidney…

The survey included 2,205 adults and was conducted on September 5, 2024

The market for oral GLP-1RAs is expanding, and Rybelsus’ latest results showed its benefits in reducing the risk in cardiovascular…

Regulator highlights risks of dosing errors and adverse events, urges healthcare providers to ensure correct syringe use and…

The study, published in the Lancet's eClinicalMedicine journal, explored more than 100 million medical records of the U.S.…

The warnings were issued on fake drugs claiming to contain the active ingredient found in Novo Nordisk's diabetes drug Ozempic…

Shift could reflect a changing demand away from oncology toward addressing metabolic disorders

The acquisition of Catalent by Novo Holdings expects to see three new manufacturing sites added to Novo Nordisk’s arsenal, to…